Conmed CORP Form 4 insider transactions

NYSE
Heather L. Cohen, EVP & Chief HR & Legal Officer of CONMED Corp, acquired 33,508 stock options on March 1, 2024, under the company's 2018 Long-Term Incentive Plan.
NYSE
Edward A. Clifford, VP Global Manufacturing at Conmed Corp, reports the acquisition of 18,988 stock options on March 1, 2024.
NYSE
Pat Beyer, President Int'l & Global Ortho at CONMED Corp, was granted 44,677 stock options on March 1, 2024, according to a Form 4 filing.
NYSE
Terence M. Berge, VP-Corporate Controller of CONMED Corp, was granted 8,000 stock options under the company's 2018 Long-Term Incentive Plan.